KPTI Working Capital Per Revenue	(Mar 31 2025) I. Quarter	(Dec 31 2024) IV. Quarter	(Sep 30 2024) III. Quarter	(Jun 30 2024) II. Quarter	(Mar 31 2024) I. Quarter
Y / Y Working Capital Change	-78.11 %	-61.71 %	-39.68 %	-35.92 %	-47.51 %
Y / Y Revenue Change	-9.39 %	-9.5 %	7.7 %	13.86 %	-14.4 %
Working Capital Per Revenue	0.65	0.82	0.97	1.13	1.32
Working Capital Per Revenue Ranking	# 1714	# 1907	# 2123	# 2357	# 0
Seq. Working Capital Change	-53.5 %	-47.89 %	-18.33 %	10.61 %	-18.66 %
Seq. Revenue Change	-1.73 %	-21.25 %	-9.36 %	29.16 %	-1.84 %

New: More KPTI's historic Working Capital Per Revenue Ratios >>

Financial strength information by company within the Major Pharmaceutical Preparations industry >> Back to KPTI Financial Strength Comparisons >> See KPTI Balance Sheets

Comment on KPTI's Working Capital Per Revenue in the first quarter 2025

Karyopharm Therapeutics Inc 's Working Capital Per Revenue in the Q1 2025 sequentially fell to 0.65 a new company low. Due to decrease of revenue year on year in the first quarter 2025 by -9.39%.

Within Healthcare sector 30 other companies have achieved lower Working Capital Per Revenue during the Q1 2025. While Karyopharm Therapeutics Inc Working Capital Per Revenue overall ranking has impoved so far in the Q1 2025 to 1714, from total ranking in the fourth quarter 2024 at 1907.

Working Capital Per Revenue Ranking
Within:	No.
Industry	# 9
Sector	# 31
S&P 500	# 1714

Working Capital Per Revenue Statistics
High	Average	Low
21.19	3.42	0.65
(Jun 30 2019)		(Mar 31 2025)

Financial Statements
Karyopharm Therapeutics Inc 's Working Capital	$ 30 Millions	Visit KPTI's Balance sheet
Karyopharm Therapeutics Inc 's Revenues	$ 30 Millions	Visit KPTI's Income Statement
Where are KPTI's Sales coming from?		Visit KPTI's Sales by Geography

Companies with similar Average Working Capital Per Revenue for 12 months ending Mar 31 2025, within Healthcare Sector	Working Capital Per Revenue
Pacific Health Care Organization Inc	1.77
Iovance Biotherapeutics inc	1.76
Arcturus Therapeutics Holdings Inc	1.72
Meiragtx Holdings Plc	1.69
Theravance Biopharma inc	1.67
Schrodinger Inc	1.67
Vanda Pharmaceuticals Inc	1.65
Cytek Biosciences Inc	1.65
Personalis Inc	1.64
Sight Sciences Inc	1.60
Zai Lab Limited	1.59
Cryoport inc	1.57
Cue Biopharma Inc	1.56
Ligand Pharmaceuticals Incorporated	1.55
Siga Technologies Inc	1.51
Spero Therapeutics Inc	1.47
Monte Rosa Therapeutics Inc	1.47
Repligen Corp	1.47
Aquestive Therapeutics Inc	1.44
Aurinia Pharmaceuticals Inc	1.40
Procept Biorobotics Corporation	1.40
Tarsus Pharmaceuticals Inc	1.36
Regenxbio Inc	1.34
Pulmonx Corporation	1.33
Arcutis Biotherapeutics Inc	1.32
Sensus Healthcare Inc	1.30
Stoke Therapeutics Inc	1.28
The Beauty Health Company	1.28
Wave Life Sciences Ltd	1.27
Lemaitre Vascular Inc	1.26

Date modified: 2025-05-15T04:09:57+00:00

Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com